BostonGene’s Precision Oncology Breakthroughs: AI-Enhanced Multi-omics and Digital Pathology
BostonGene has secured top honors in five categories in the 2024 Pharmaceutical Excellence Awards – Business Expansion, Research and Development (R&D), Innovation, Product Launches and